Jenny Sundqvist
Chief Executive Officer at FLERIE INVEST AB
Net worth: 5 435 $ as of 2024-06-29
Profile
Jenny Sundqvist is currently the Chief Executive Officer at InDex Pharmaceuticals Holding AB.
Previously, she worked as the Chief Commercial Officer at Isofol Medical AB.
From 2017 to 2021, she held the position of Head-Oncology Portfolio at AstraZeneca PLC.
Ms. Sundqvist completed her undergraduate degree at Louisiana State University and obtained an MBA from McCombs School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
FLERIE AB
0.00% | 2023-12-30 | 121,951 ( 0.00% ) | 5 435 $ | 2024-06-29 |
Jenny Sundqvist active positions
| Companies | Position | Start |
|---|---|---|
| FLERIE INVEST AB | Chief Executive Officer | 2022-12-31 |
Former positions of Jenny Sundqvist
| Companies | Position | End |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 2021-03-31 |
| ISOFOL MEDICAL AB | Corporate Officer/Principal | - |
Training of Jenny Sundqvist
| Louisiana State University | Undergraduate Degree |
| McCombs School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ISOFOL MEDICAL AB | Health Technology |
| FLERIE INVEST AB | Health Technology |
| ASTRAZENECA PLC | Health Technology |
- Stock Market
- Insiders
- Jenny Sundqvist
